Clinical trial
A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
NCT02954094 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Longitudinal Observational Study of the Natural History and Management of Patients With Hepatocellular Carcinoma
- Lead sponsor
- Target PharmaSolutions, Inc.
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- December 31, 2016
- Completion date
- February 28, 2027
- Enrollment
- 10,000 (estimated)
- Sites
- 71
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular cancer